Left Menu
Development News Edition

EXCLUSIVE-Brazil will have a COVID-19 vaccine by June 2021, says regulator

Torres said that, to date, the agency had received no data or request for approval of Sputnik V trial protocols. Torres said the Butantan Institute and the federal FioCruz biomedical center in Rio de Janeiro have the capacity to produce millions of doses of vaccines for Brazil and probably for other Latin American nations.

Reuters | Brasilia | Updated: 30-10-2020 02:34 IST | Created: 30-10-2020 01:10 IST
EXCLUSIVE-Brazil will have a COVID-19 vaccine by June 2021, says regulator
Representative Image Image Credit: ANI

Brazil expects to have a vaccine against COVID-19 approved and ready for use in a national inoculation program by June, the head of the country's health regulator Anvisa, Antonio Barra Torres, said on Thursday. With the world's worst outbreak of coronavirus after the United States and India, Brazil has become a key testing ground and has approved late stage clinical trials for four vaccines that are under development.

Torres told Reuters that Anvisa has not decided on the minimum efficacy to require but he said the agency has approved vaccines in the past with less than 50% effectiveness. Health authorities in Europe are debating whether to accept a so-called efficacy rate of less than 50% to be able to deliver a vaccine sooner, the Wall Street Journal reported this week.

Sandra Gallina, Director General for Health and Food Safety at the European Commission told EU lawmakers in a hearing that the article was speculation, but then added that it's not rare to have vaccines that only work with 50% efficacy. Last week, Brazil's right-wing President Jair Bolsonaro disavowed a decision by his health minister to buy 46 million doses of a vaccine from China's Sinovac Biotech called CoronaVac, saying "We will not buy a Chinese vaccine."

But Torres said Anvisa could register more than one of the four candidates now being tested in Brazil - from Oxford University/AstraZeneca, China's Sinovac Biotech, Pfizer Inc in partnership with BioNTech and Johnson & Johnson's pharmaceutical subsidiary Janssen - irrespective of their country of origin. "The origin of the vaccine has no bearing for us, there is no prejudice," he said.

Two days after Bolsonaro's comments, Anvisa authorized Sao Paulo's Butantan Institute to import 6 million doses of CoronaVac and on Wednesday further authorized the biomedical center to import the raw ingredients to make another 40 million doses in Brazil. Russia has agreed to supply its Sputnik V vaccine to the Brazilian states of Parana and Bahia, but it must first be tested and approved by Anvisa. Torres said that, to date, the agency had received no data or request for approval of Sputnik V trial protocols.

Torres said the Butantan Institute and the federal FioCruz biomedical center in Rio de Janeiro have the capacity to produce millions of doses of vaccines for Brazil and probably for other Latin American nations. Anvisa is in talks with some Latin American countries about them accepting its registration of vaccines that will be made in Brazil, he said.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Videos

Latest News

Australian state eases restrictions for 'COVID safe' summer

Australias Victoria state eased COVID-19 restrictions on Sunday after the countrys pandemic hotspot recorded 37 days without any new coronavirus infections, moving toward a COVID-safe holiday season. From midnight on Sunday, up to 100 peopl...

Mexico registers 11,625 new coronavirus cases, 593 more deaths

Mexicos Health Ministry on Saturday reported 11,625 new confirmed cases of coronavirus infection and an additional 593 fatalities, bringing the total in the country to 1,168,395 cases and 109,456 deaths.The government says the real number o...

Trump stumps in Georgia for two Republican candidates while pressing vote fraud claims

U.S. President Donald Trump campaigned in Georgia on Saturday for two Republican senators at a rally that some in his party fear could end up hurting, not helping, their chances if he focuses on efforts to reverse his own election defeat. I...

S.Korea to consider new curbs as coronavirus cases hit 9-month high

South Korea on Sunday reported 631 new coronavirus cases, the highest in nine months, ahead of an expected government decision on whether to further tighten social distancing curbs as health authorities struggle to contain a third wave of o...

Give Feedback